Medicament classification for mouthwash depends on therapeutic attributes, dominant use, and trade understanding, not isolated factors.

Classification of Senquel-AD Mouthwash under the KVAT regime turned on whether the product was a medicament or merely a mouthwash. The Court noted that classification must be decided cumulatively on curative, therapeutic or prophylactic attributes, dominant use, user understanding, trade perception, and the material produced, rather than on any single factor such as packing, over-the-counter sale or absence of prescription. It also treated pharmaceutical ingredients and accepted use of similar products as relevant, and placed the burden on the revenue to show that any curative value was only subsidiary. The adverse classification could not be sustained on the existing material, so the clarification order was set aside and the matter remitted for reconsideration in accordance with law.

---

---

Issues: Whether Senquel-AD Mouthwash was classifiable as a medicament under the KVAT regime or fell under the mouthwash entry for the purpose of tax.

Analysis: Classification depended on the product's curative, therapeutic, or prophylactic attributes, the understanding of users and the dominant use of the product, and not on any single test such as packing, over-the-counter sale, or the mere absence of a prescription. The presence of pharmaceutical ingredients, the effect of the product as disclosed in the material produced, the fact that similar products had been accepted as medicaments, and the burden on the revenue to show that curative value was only subsidiary were all relevant. The authority had rejected the claim mainly on the footing that no material was produced and that the product did not treat a specific disease condition, without properly considering the literature and the applicable classification principles.

Conclusion: The adverse classification of Senquel-AD Mouthwash could not be sustained on the material before the authority, and the matter required fresh consideration.

Final Conclusion: The impugned clarification order was set aside and the issue was sent back for reconsideration in accordance with law.

Ratio Decidendi: A product with therapeutic or prophylactic ingredients must be classified on a cumulative assessment of its curative attributes, dominant use, and trade understanding, and the revenue carries the burden to justify exclusion from the medicament entry.

---